Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Complement component 3 (C3) genetics and diabetes mellitus.

S Krantz1, F Stelter, M Lober

  • 1Institute of Biochemistry, Ernst Moritz Arndt University, Greifswald, FRG.

Biomedica Biochimica Acta
|January 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

ZEB1 stratifies the response to Sorafenib and Mdivi-1 combination therapy in hepatocellular carcinoma.

Scientific reports·2025
Same author

Supply chain and marketing of sea grapes, <i>Caulerpa racemosa</i> (Forsskål) J. Agardh (Chlorophyta: Caulerpaceae) in Fiji, Samoa and Tonga.

Journal of applied phycology·2014
Same author

Fundamental Studies of Fiber-Guided Soft Tissue Cutting by Means of Pulsed Midinfrared Lasers and their Application in Ureterotomy.

Journal of biomedical optics·2012
Same author

Anemia in the elderly-clinical findings and impact on health.

Critical reviews in oncology/hematology·2006
Same author

A temperature-dependent inhibitory activity of serum on the capacity of Saccharomyces cerevisiae-derived hepatitis B surface antigen to bind to monocytes.

Archives of virology·2004
Same author

Binding of Amadori glucose-modified albumin by the monocytic cell line MonoMac 6 activates protein kinase C epsilon protein tyrosine kinases and the transcription factors AP-1 and NF-kappaB.

Glycoconjugate journal·2002
Same journal

Intracerebroventricular administration of hypertonic sodium chloride solution reduces the sensitivity of the baroreceptor heart reflex in anaesthetized rats.

Biomedica biochimica acta·1991
Same journal

An efficient chemical-enzymatic synthesis of LHRH N-terminal pentapeptide.

Biomedica biochimica acta·1991
Same journal

Adrenergic cardiovascular actions in rats as affected by dichloromethane exposure.

Biomedica biochimica acta·1991
Same journal

Lipoxygenase-inhibitory action of antiviral polymeric oxidation products of polyphenols.

Biomedica biochimica acta·1991
Same journal

Uptake of lysine and incorporation into proteins of the cortex during a short-term hypoxia of neonatal rats.

Biomedica biochimica acta·1991
Same journal

Influence of intestinal resection, type of dietary fat and time on the digestive and metabolic utilization of fat in rats.

Biomedica biochimica acta·1991
See all related articles

Complement component 3 (C3) genes do not appear to increase risk for type-1 or type-2 diabetes, or related conditions like heart disease and hypertension. C3 is not a reliable genetic marker for these diseases.

Area of Science:

  • Genetics
  • Immunology
  • Metabolic Diseases

Background:

  • Complement component 3 (C3) plays a role in immune responses.
  • Genetic factors are investigated for their influence on diabetes and cardiovascular diseases.
  • Previous research suggested potential links between C3 and various health conditions.

Purpose of the Study:

  • To investigate the association between complement component 3 (C3) phenotypes and allele frequencies with type-1 and type-2 diabetes.
  • To assess the role of C3 genes in the susceptibility to late diabetic complications, atherosclerosis, and essential hypertension.
  • To evaluate the combined effect of C3 and apolipoprotein E (apo E) genes on these conditions.

Main Methods:

  • Phenotyping and allele frequency analysis of Complement component 3 (C3) in European populations.

Related Experiment Videos

  • Inclusion of patient cohorts with type-1 diabetes, type-2 diabetes, coronary heart disease, and arterial hypertension.
  • Comparison with control groups including non-diabetic relatives and blood donors.

    • Main Results:

    • No significant evidence found linking C3 genes to susceptibility to type-1 or type-2 diabetes.
    • C3 genes did not show association with late diabetic complications, atherosclerosis, or essential hypertension.
    • Apolipoprotein E (apo E) phenotype distribution was similar in patients and controls; combined C3 and apo E analysis did not improve results.

    Conclusions:

    • Complement component 3 (C3) is not a significant genetic risk factor for type-1 or type-2 diabetes.
    • C3 genes do not appear to influence the development of atherosclerosis or hypertension.
    • Caution is advised when considering C3 as a genetic marker for these diseases.